Europe Avanafil (Cas 330784-47-9) Market Report 2017

January 2017 | 103 pages | ID: EDF7ED4C7B4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Avanafil (Cas 330784-47-9)

Revenue, means the sales value of Avanafil (Cas 330784-47-9)

This report studies sales (consumption) of Avanafil (Cas 330784-47-9) in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• VIVUS
• Menarini Group
• Auxilium Pharmaceuticals, Inc
• Sanofi
• Endo International
• JW Pharmaceutical

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Avanafil (Cas 330784-47-9) in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• By Dosage
• 50mg
• 100mg
• 200mg
• By Purity
• ≥99%
• Other

Split by application, this report focuses on sales, market share and growth rate of Avanafil (Cas 330784-47-9) in each application, can be divided into

• Pharmaceutical
• Other

Contents

Europe Avanafil (Cas 330784-47-9) Market Report 2017

1 AVANAFIL (CAS 330784-47-9) OVERVIEW

1.1 Product Overview and Scope of Avanafil (Cas 330784-47-9)
1.2 Classification of Avanafil (Cas 330784-47-9)
  1.2.1 By Dosage
  1.2.2 50mg
  1.2.3 100mg
  1.2.4 200mg
  1.2.5 By Purity
  1.2.6 ≥99%
  1.2.7 Other
1.3 Application of Avanafil (Cas 330784-47-9)
  1.3.1 Pharmaceutical
  1.3.2 Other
1.4 Avanafil (Cas 330784-47-9) Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Avanafil (Cas 330784-47-9) (2011-2021)
  1.5.1 Europe Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2021)
  1.5.2 Europe Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)

2 EUROPE AVANAFIL (CAS 330784-47-9) BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Avanafil (Cas 330784-47-9) Market Competition by Manufacturers
  2.1.1 Europe Avanafil (Cas 330784-47-9) Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Avanafil (Cas 330784-47-9) Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Avanafil (Cas 330784-47-9) (Volume and Value) by Type
  2.2.1 Europe Avanafil (Cas 330784-47-9) Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Avanafil (Cas 330784-47-9) Revenue and Market Share by Type (2011-2016)
2.3 Europe Avanafil (Cas 330784-47-9) (Volume and Value) by Countries
  2.3.1 Europe Avanafil (Cas 330784-47-9) Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Avanafil (Cas 330784-47-9) Revenue and Market Share by Countries (2011-2016)
2.4 Europe Avanafil (Cas 330784-47-9) (Volume) by Application

3 GERMANY AVANAFIL (CAS 330784-47-9) (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Avanafil (Cas 330784-47-9) Sales and Value (2011-2016)
  3.1.1 Germany Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
  3.1.2 Germany Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
3.2 Germany Avanafil (Cas 330784-47-9) Sales and Market Share by Manufacturers
3.3 Germany Avanafil (Cas 330784-47-9) Sales and Market Share by Type
3.4 Germany Avanafil (Cas 330784-47-9) Sales and Market Share by Application

4 FRANCE AVANAFIL (CAS 330784-47-9) (VOLUME, VALUE AND SALES PRICE)

4.1 France Avanafil (Cas 330784-47-9) Sales and Value (2011-2016)
  4.1.1 France Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
  4.1.2 France Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
  4.1.4 France Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
4.2 France Avanafil (Cas 330784-47-9) Sales and Market Share by Manufacturers
4.3 France Avanafil (Cas 330784-47-9) Sales and Market Share by Type
4.4 France Avanafil (Cas 330784-47-9) Sales and Market Share by Application

5 UK AVANAFIL (CAS 330784-47-9) (VOLUME, VALUE AND SALES PRICE)

5.1 UK Avanafil (Cas 330784-47-9) Sales and Value (2011-2016)
  5.1.1 UK Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
  5.1.2 UK Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
  5.1.5 UK Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
5.2 UK Avanafil (Cas 330784-47-9) Sales and Market Share by Manufacturers
5.3 UK Avanafil (Cas 330784-47-9) Sales and Market Share by Type
5.4 UK Avanafil (Cas 330784-47-9) Sales and Market Share by Application

6 RUSSIA AVANAFIL (CAS 330784-47-9) (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Avanafil (Cas 330784-47-9) Sales and Value (2011-2016)
  6.1.1 Russia Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
  6.1.2 Russia Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
6.2 Russia Avanafil (Cas 330784-47-9) Sales and Market Share by Manufacturers
6.3 Russia Avanafil (Cas 330784-47-9) Sales and Market Share by Type
6.4 Russia Avanafil (Cas 330784-47-9) Sales and Market Share by Application

7 ITALY AVANAFIL (CAS 330784-47-9) (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Avanafil (Cas 330784-47-9) Sales and Value (2011-2016)
  7.1.1 Italy Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
  7.1.2 Italy Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
7.2 Italy Avanafil (Cas 330784-47-9) Sales and Market Share by Manufacturers
7.3 Italy Avanafil (Cas 330784-47-9) Sales and Market Share by Type
7.4 Italy Avanafil (Cas 330784-47-9) Sales and Market Share by Application

8 SPAIN AVANAFIL (CAS 330784-47-9) (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Avanafil (Cas 330784-47-9) Sales and Value (2011-2016)
  8.1.1 Spain Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
  8.1.2 Spain Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
8.2 Spain Avanafil (Cas 330784-47-9) Sales and Market Share by Manufacturers
8.3 Spain Avanafil (Cas 330784-47-9) Sales and Market Share by Type
8.4 Spain Avanafil (Cas 330784-47-9) Sales and Market Share by Application

9 BENELUX AVANAFIL (CAS 330784-47-9) (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Avanafil (Cas 330784-47-9) Sales and Value (2011-2016)
  9.1.1 Benelux Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
9.2 Benelux Avanafil (Cas 330784-47-9) Sales and Market Share by Manufacturers
9.3 Benelux Avanafil (Cas 330784-47-9) Sales and Market Share by Type
9.4 Benelux Avanafil (Cas 330784-47-9) Sales and Market Share by Application

10 EUROPE AVANAFIL (CAS 330784-47-9) MANUFACTURERS ANALYSIS

10.1 VIVUS
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    10.1.2.1 By Dosage
    10.1.2.2 50mg
  10.1.3 VIVUS Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Menarini Group
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    10.2.2.1 By Dosage
    10.2.2.2 50mg
  10.2.3 Menarini Group Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Auxilium Pharmaceuticals, Inc
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    10.3.2.1 By Dosage
    10.3.2.2 50mg
  10.3.3 Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Sanofi
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    10.4.2.1 By Dosage
    10.4.2.2 50mg
  10.4.3 Sanofi Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Endo International
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    10.5.2.1 By Dosage
    10.5.2.2 50mg
  10.5.3 Endo International Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 JW Pharmaceutical
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    10.6.2.1 By Dosage
    10.6.2.2 50mg
  10.6.3 JW Pharmaceutical Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview

11 AVANAFIL (CAS 330784-47-9) MANUFACTURING COST ANALYSIS

11.1 Avanafil (Cas 330784-47-9) Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Avanafil (Cas 330784-47-9) Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE AVANAFIL (CAS 330784-47-9) MARKET FORECAST (2016-2021)

14.1 Germany Avanafil (Cas 330784-47-9) Sales Forecast (2016-2021)
14.2 France Avanafil (Cas 330784-47-9) Sales Forecast (2016-2021)
14.3 UK Avanafil (Cas 330784-47-9) Sales Forecast (2016-2021)
14.4 Russia Avanafil (Cas 330784-47-9) Sales Forecast (2016-2021)
14.5 Italy Avanafil (Cas 330784-47-9) Sales Forecast (2016-2021)
14.6 Spain Avanafil (Cas 330784-47-9) Sales Forecast (2016-2021)
14.7 Benelux Avanafil (Cas 330784-47-9) Sales Forecast (2016-2021)
14.8 Europe Avanafil (Cas 330784-47-9) Sales Forecast by Type (2016-2021)
14.9 Europe Avanafil (Cas 330784-47-9) Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Avanafil (Cas 330784-47-9)
Table Classification of Avanafil (Cas 330784-47-9)
Figure Europe Sales Market Share of Avanafil (Cas 330784-47-9) by Type in 2015
Figure By Dosage Picture
Figure 50mg Picture
Figure 100mg Picture
Figure 200mg Picture
Figure By Purity Picture
Figure ≥99% Picture
Figure Other Picture
Table Application of Avanafil (Cas 330784-47-9)
Figure Europe Sales Market Share of Avanafil (Cas 330784-47-9) by Application in 2015
Figure Pharmaceutical Examples
Figure Other Examples
Figure Germany Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Figure France Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Figure UK Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Figure Russia Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Figure Italy Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Figure Spain Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Figure Benelux Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Figure Europe Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2021)
Figure Europe Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Table Europe Avanafil (Cas 330784-47-9) Sales of Key Manufacturers (2015 and 2016)
Table Europe Avanafil (Cas 330784-47-9) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Avanafil (Cas 330784-47-9) Sales Share by Manufacturers
Figure 2016 Avanafil (Cas 330784-47-9) Sales Share by Manufacturers
Table Europe Avanafil (Cas 330784-47-9) Revenue by Manufacturers (2015 and 2016)
Table Europe Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers
Table 2016 Europe Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers
Table Europe Avanafil (Cas 330784-47-9) Sales and Market Share by Type (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Sales Share by Type (2011-2016)
Figure Sales Market Share of Avanafil (Cas 330784-47-9) by Type (2011-2016)
Figure Europe Avanafil (Cas 330784-47-9) Sales Growth Rate by Type (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Revenue and Market Share by Type (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Avanafil (Cas 330784-47-9) by Type (2011-2016)
Figure Europe Avanafil (Cas 330784-47-9) Revenue Growth Rate by Type (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Sales and Market Share by Countries (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Sales Share by Countries (2011-2016)
Figure Sales Market Share of Avanafil (Cas 330784-47-9) by Countries (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Revenue and Market Share by Countries (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Avanafil (Cas 330784-47-9) by Countries (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Sales and Market Share by Application (2011-2016)
Table Europe Avanafil (Cas 330784-47-9) Sales Share by Application (2011-2016)
Figure Sales Market Share of Avanafil (Cas 330784-47-9) by Application (2011-2016)
Figure Germany Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
Figure Germany Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
Figure Germany Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
Table Germany Avanafil (Cas 330784-47-9) Sales by Manufacturers (2015 and 2016)
Table Germany Avanafil (Cas 330784-47-9) Market Share by Manufacturers (2015 and 2016)
Table Germany Avanafil (Cas 330784-47-9) Sales by Type (2015 and 2016)
Table Germany Avanafil (Cas 330784-47-9) Market Share by Type (2015 and 2016)
Table Germany Avanafil (Cas 330784-47-9) Sales by Application (2015 and 2016)
Table Germany Avanafil (Cas 330784-47-9) Market Share by Application (2015 and 2016)
Figure France Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
Figure France Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
Figure France Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
Table France Avanafil (Cas 330784-47-9) Sales by Manufacturers (2015 and 2016)
Table France Avanafil (Cas 330784-47-9) Market Share by Manufacturers (2015 and 2016)
Table France Avanafil (Cas 330784-47-9) Sales by Type (2015 and 2016)
Table France Avanafil (Cas 330784-47-9) Market Share by Type (2015 and 2016)
Table France Avanafil (Cas 330784-47-9) Sales by Application (2015 and 2016)
Table France Avanafil (Cas 330784-47-9) Market Share by Application (2015 and 2016)
Figure UK Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
Figure UK Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
Figure UK Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
Table UK Avanafil (Cas 330784-47-9) Sales by Manufacturers (2015 and 2016)
Table UK Avanafil (Cas 330784-47-9) Market Share by Manufacturers (2015 and 2016)
Table UK Avanafil (Cas 330784-47-9) Sales by Type (2015 and 2016)
Table UK Avanafil (Cas 330784-47-9) Market Share by Type (2015 and 2016)
Table UK Avanafil (Cas 330784-47-9) Sales by Application (2015 and 2016)
Table UK Avanafil (Cas 330784-47-9) Market Share by Application (2015 and 2016)
Figure Russia Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
Figure Russia Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
Figure Russia Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
Table Russia Avanafil (Cas 330784-47-9) Sales by Manufacturers (2015 and 2016)
Table Russia Avanafil (Cas 330784-47-9) Market Share by Manufacturers (2015 and 2016)
Table Russia Avanafil (Cas 330784-47-9) Sales by Type (2015 and 2016)
Table Russia Avanafil (Cas 330784-47-9) Market Share by Type (2015 and 2016)
Table Russia Avanafil (Cas 330784-47-9) Sales by Application (2015 and 2016)
Table Russia Avanafil (Cas 330784-47-9) Market Share by Application (2015 and 2016)
Figure Italy Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
Figure Italy Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
Figure Italy Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
Table Italy Avanafil (Cas 330784-47-9) Sales by Manufacturers (2015 and 2016)
Table Italy Avanafil (Cas 330784-47-9) Market Share by Manufacturers (2015 and 2016)
Table Italy Avanafil (Cas 330784-47-9) Sales by Type (2015 and 2016)
Table Italy Avanafil (Cas 330784-47-9) Market Share by Type (2015 and 2016)
Table Italy Avanafil (Cas 330784-47-9) Sales by Application (2015 and 2016)
Table Italy Avanafil (Cas 330784-47-9) Market Share by Application (2015 and 2016)
Figure Spain Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
Figure Spain Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
Figure Spain Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
Table Spain Avanafil (Cas 330784-47-9) Sales by Manufacturers (2015 and 2016)
Table Spain Avanafil (Cas 330784-47-9) Market Share by Manufacturers (2015 and 2016)
Table Spain Avanafil (Cas 330784-47-9) Sales by Type (2015 and 2016)
Table Spain Avanafil (Cas 330784-47-9) Market Share by Type (2015 and 2016)
Table Spain Avanafil (Cas 330784-47-9) Sales by Application (2015 and 2016)
Table Spain Avanafil (Cas 330784-47-9) Market Share by Application (2015 and 2016)
Figure Benelux Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2016)
Figure Benelux Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2016)
Figure Benelux Avanafil (Cas 330784-47-9) Sales Price Trend (2011-2016)
Table Benelux Avanafil (Cas 330784-47-9) Sales by Manufacturers (2015 and 2016)
Table Benelux Avanafil (Cas 330784-47-9) Market Share by Manufacturers (2015 and 2016)
Table Benelux Avanafil (Cas 330784-47-9) Sales by Type (2015 and 2016)
Table Benelux Avanafil (Cas 330784-47-9) Market Share by Type (2015 and 2016)
Table Benelux Avanafil (Cas 330784-47-9) Sales by Application (2015 and 2016)
Table Benelux Avanafil (Cas 330784-47-9) Market Share by Application (2015 and 2016)
Table Avanafil (Cas 330784-47-9) Basic Information List
Table VIVUS Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure VIVUS Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Menarini Group Basic Information List
Table Menarini Group Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Menarini Group Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Auxilium Pharmaceuticals, Inc Basic Information List
Table Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Endo International Basic Information List
Table Endo International Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo International Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table JW Pharmaceutical Basic Information List
Table JW Pharmaceutical Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table JW Pharmaceutical Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Avanafil (Cas 330784-47-9)
Figure Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)
Figure Avanafil (Cas 330784-47-9) Industrial Chain Analysis
Table Raw Materials Sources of Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
Table Major Buyers of Avanafil (Cas 330784-47-9)
Table Distributors/Traders List
Figure Germany Avanafil (Cas 330784-47-9) Sales and Growth Rate Forecast (2016-2021)
Figure Germany Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Figure France Avanafil (Cas 330784-47-9) Sales and Growth Rate Forecast (2016-2021)
Figure France Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Figure UK Avanafil (Cas 330784-47-9) Sales and Growth Rate Forecast (2016-2021)
Figure UK Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Avanafil (Cas 330784-47-9) Sales and Growth Rate Forecast (2016-2021)
Figure Russia Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Avanafil (Cas 330784-47-9) Sales and Growth Rate Forecast (2016-2021)
Figure Italy Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Avanafil (Cas 330784-47-9) Sales and Growth Rate Forecast (2016-2021)
Figure Spain Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Avanafil (Cas 330784-47-9) Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Table Europe Avanafil (Cas 330784-47-9) Sales Forecast by Type (2016-2021)
Table Europe Avanafil (Cas 330784-47-9) Sales Forecast by Application (2016-2021)